Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MEDIFAST INC Director's Dealing 2020

Jan 3, 2020

33899_dirs_2020-01-03_4baa4c8f-539e-4727-8228-79e0b4aa60ff.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MEDIFAST INC (MED)
CIK: 0000910329
Period of Report: 2019-12-31

Reporting Person: ROBINSON TIMOTHY G (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-12-31 Common Stock M 37950.00 Acquired 64574.00 Direct
2019-12-31 Common Stock F 18190.00 $109.58 Disposed 46384.00 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-12-31 Performance Stock Units $ M 37950.00 Disposed Common Stock (37950.00) Direct

Footnotes

F1: 37,950 Performance Stock Units were granted on February 16, 2017, vested on December 31, 2019 and converted into common stock on a one-for-one basis.